News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 19, 2014, 17:37 ET

Boston Scientific Earns Top Marks In Corporate Equality Index

Boston Scientific has scored the highest rating of 100 percent in the Human Rights Campaign (HRC) Foundation's 2015 Corporate...

Nov 17, 2014, 09:00 ET

First U.S. Procedures Completed With The Symphion™ Hysteroscopic Tissue Removal System

 Boston Scientific Corporation (NYSE: BSX) announces the completion of the first U.S. procedures performed with the Symphion System, designed...

Nov 13, 2014, 17:07 ET

Subcutaneous Implantable Defibrillator Receives Favorable Coding And Payment Designations For 2015

Boston Scientific Corporation (NYSE: BSX) announced that its subcutaneous implantable defibrillator (S-ICD System™) will have...

Nov 05, 2014, 08:30 ET

Boston Scientific To Participate In 2014 Stifel Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Stifel Healthcare Conference on Tuesday, November 18, 2014 in New...

Nov 04, 2014, 08:30 ET

Boston Scientific To Host And Webcast Investor Event

 Boston Scientific Corporation (NYSE: BSX) today announced that it will be holding an analyst event on November 19, 2014 to provide an update...

Nov 03, 2014, 09:00 ET

Boston Scientific Announces Schedule For Presentations At The Upcoming North American Neuromodulation Society (NANS) Meeting

Boston Scientific Corporation (NYSE: BSX) is reinforcing the company's commitment to developing innovative and effective therapies in...

Oct 30, 2014, 08:30 ET

Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Credit Suisse Annual Healthcare Conference on Tuesday, November...

Oct 22, 2014, 07:00 ET

Boston Scientific Announces Results For Third Quarter Ended September 30, 2014

Boston Scientific Corporation (NYSE: BSX) generated sales of $1.846 billion during the third quarter ended September 30, 2014, compared to the...

Oct 21, 2014, 09:00 ET

Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge™ Surgical Leads For The Precision Spectra™ Spinal Cord Stimulator (SCS) System

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) and CE Mark approval for the CoverEdge™ 32 and...

Oct 20, 2014, 08:00 ET

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

 As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM...

Oct 16, 2014, 16:30 ET

Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADETM pacemaker family. When implanted with the company's...

Oct 08, 2014, 19:59 ET

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

 After reviewing updated data and analysis for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN™ Left Atrial Appendage Closure...

Oct 01, 2014, 08:30 ET

Boston Scientific To Webcast Conference Call Discussing Third Quarter 2014 Financial Results On October 22

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third...

Sep 23, 2014, 16:05 ET

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of...

Sep 17, 2014, 00:00 ET

Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor

 Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise™ Deep Brain Stimulation (DBS) System for the treatment of...

Sep 10, 2014, 09:00 ET

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for...

Sep 03, 2014, 08:00 ET

Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Bank of America Merrill Lynch Global Healthcare Conference on...

Sep 02, 2014, 08:00 ET

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

 Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG....

Aug 30, 2014, 12:38 ET

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

 Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the...

Aug 29, 2014, 17:00 ET

Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents

 A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture...